Target intelligence / Profile preview

Endogenous retrovirus group K13 member 1 (ERVK13-1)

Target
ERVK13-1
Molecular classification
Other (endogenous retrovirus envelope polyprotein/gene), Structural molecule (predicted by gene ontology)
01

Overview

Endogenous retrovirus group K13 member 1 (ERVK13-1) is a human gene derived from a retroviral ancestor. It encodes a predicted envelope polyprotein with structural similarity to retroviral Env proteins, which typically mediate receptor recognition and membrane fusion in viruses. In humans, ERVK13-1 is part of the long non-coding RNA gene class and has no confirmed protein coding function; in other retroviral family members, Env proteins are important in cell fusion processes, including placental morphogenesis (as in syncytin proteins). ERVK13-1 and related HERV-K envelope proteins are differentially expressed in cancer, neurodegeneration, and infection, suggesting possible roles in pathology, but their direct biological and therapeutic significance remains uncertain. Key functional features: Located in the plasma membrane (by prediction); Envelope protein domains may facilitate membrane fusion and cell-cell fusion (by analogy); Expression patterns are altered in disease states, but functional consequence for ERVK13-1 is not established; No approved drugs, biomarkers, or therapies targeting ERVK13-1; Multiple aliases exist due to gene/protein modularity and annotation differences. The target is correctly specified as a human endogenous retrovirus envelope gene and is not recognized as a canonical receptor, enzyme, or drug target. No major inconsistencies or errors are present in the input.

Other names
Endogenous retrovirus group K member 13-1 Env polyproteinSurface protein (SU)Transmembrane protein (TM)Envelope polyproteinHERV-K_16p13.3 provirus ancestral Env polyproteinHERV-K_16p3.3 provirus ancestral Env polyprotein
02

Biological functions

Membrane fusion (retroviral mechanism, by analogy to other ENV proteins; not confirmed for ERVK13-1 specifically)Receptor recognition (for ancestral retroviral entry; evidence by similarity to other ENV proteins)Possible modulator of cell-cell fusion (see syncytin-type env proteins)Unknown (ERVK13-1 encodes a long non-coding RNA transcript of unknown function; envelop gene may be defective)
03

Disease associations

Cancer (some HERV env proteins, not specifically ERVK13-1, are upregulated in various cancers and may contribute to oncogenic processes)Neurodegenerative disease (other HERV envelope genes, including HERV-K, have been linked to neurological disorders; role of ERVK13-1 is not specifically established)Infection (expression can change in response to viral infections including SARS-CoV-2/COVID-19 through co-activation)Other (potential involvement in placental development, but not clearly defined for ERVK13-1)
04

Safety considerations

Potential for immunogenicity or autoreactivity if ERV envelope proteins are aberrantly expressedNo known safety concerns directly tied to ERVK13-1 as a drug target

Beyond the preview

Go deeper on Endogenous retrovirus group K13 member 1 (ERVK13-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous retrovirus group K13 member 1 (ERVK13-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call